Clinical Research Directory
Browse clinical research sites, groups, and studies.
Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency Emphysema
Sponsor: Sanofi
Summary
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema
Official title: A Phase 2, Single Arm, Open Label Extension Study, Evaluating the Long-Term Safety and Clinical Efficacy of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency (AATD) Emphysema
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
185
Start Date
2024-06-20
Completion Date
2028-09-30
Last Updated
2025-10-24
Healthy Volunteers
No
Conditions
Interventions
SAR447537
A1PI, Recombinant, Bivalent Fc Fusion Protein
Locations (40)
UAB Lung Health Center- Site Number : 105
Birmingham, Alabama, United States
St Joseph's Hospital and Medical Center- Site Number : 126
Phoenix, Arizona, United States
David Geffen School of Medicine at UCLA- Site Number : 124
Los Angeles, California, United States
University of California Davis Medical Center- Site Number : 110
Sacramento, California, United States
National Jewish Medical and Research Center- Site Number : 123
Denver, Colorado, United States
Nuvance Health Medical Practices, Pulmonary & Sleep Specialists- Site Number : 119
Danbury, Connecticut, United States
University of Florida - Gainesville - 1600 SW Archer Rd- Site Number : 101
Gainesville, Florida, United States
Indiana University- Site Number : 127
Indianapolis, Indiana, United States
Brigham and Women's Hospital -75 Francis Street- Site Number : 131
Boston, Massachusetts, United States
University of Minnesota-420 Delaware Str SE- Site Number : 125
Minneapolis, Minnesota, United States
Hannibal Regional Healthcare System-HRMG-Hannibal- Site Number : 111
Hannibal, Missouri, United States
Columbia University Irving Medical Center- Site Number : 104
New York, New York, United States
Oregon Health and Science University- Site Number : 117
Portland, Oregon, United States
Penn State Health Milton S. Hershey Medical Center- Site Number : 122
Hershey, Pennsylvania, United States
Temple University Hospital - 3401 N Broad St- Site Number : 130
Philadelphia, Pennsylvania, United States
Velocity Clinical Research - Spartanburg - PPDS- Site Number : 120
Spartanburg, South Carolina, United States
Houston Methodist Hospital- Site Number : 113
Houston, Texas, United States
University of Utah Health Care- Site Number : 106
Salt Lake City, Utah, United States
Investigational Site Number : 202
Chermside, Queensland, Australia
Investigational Site Number : 204
South Brisbane, Queensland, Australia
Investigational Site Number : 201
North Adelaide, South Australia, Australia
Investigational Site Number : 207
Box Hill, Victoria, Australia
Investigational Site Number : 203
Fitzroy, Victoria, Australia
Investigational Site Number : 205
Frankston, Victoria, Australia
Investigational Site Number : 701
Hellerup, Denmark
Investigational Site Number : 702
Vejle, Denmark
Investigational Site Number : 501
Dublin, Dublin, Ireland
Investigational Site Number : 403
Auckland, New Zealand
Investigational Site Number : 404
Wellington, New Zealand
Investigational Site Number : 801
Warsaw, Masovian Voivodeship, Poland
Investigational Site Number : 802
Krakow, Poland
Investigational Site Number : 901
Santander, Cantabria, Spain
Investigational Site Number : 902
Madrid, Spain
Investigational Site Number : 903
Santiago de Compostela, Spain
Investigational Site Number : 601
Gothenburg, Sweden
Investigational Site Number : 308
Dundee, Angus, United Kingdom
Investigational Site Number : 306
Wythenshawe, Cheshire, United Kingdom
Investigational Site Number : 307
Exeter, Devon, United Kingdom
Investigational Site Number : 304
Southampton, Hampshire, United Kingdom
Investigational Site Number : 309
Coventry, United Kingdom